Jason Jarzembowski, M.D., Ph.D.
414-266-7260
414-266-2779
Dr. Jarzembowski earned his Ph.D. from the University of Wisconsin – Madison (1998) and his M.D. with research honors from the Medical College of Wisconsin (2002). He was a resident in anatomic and clinical pathology at the University of Michigan from 2002 to 2006. He then trained with Dr. Louis Dehner at Washington University in St. Louis, completing a fellowship in pediatric pathology in 2007. In July of 2007, Dr. Jarzembowski was appointed as Assistant Professor at the Medical College of Wisconsin and Staff Pathologist at Children’s Hospital of Wisconsin. He is board-certified in anatomic and clinical pathology, and also holds subspecialty certification in pediatric pathology.
Dr. Jarzembowski is especially interested in pediatric solid tumors, perinatal pathology, and placental pathology. He supervises a research program studying molecular abnormalities of the pediatric tumor neuroblastoma for which he was awarded the Young Investigator Research Award by the Society for Pediatric Pathology in 2005. He serves on the Editorial Board of the journals Archives of Pathology and Laboratory Medicine and Clinical Medicine: Pathology, and is a member of the United States and Canadian Academy of Pathology, the Society for Pediatric Pathology, the College of American Pathologists, the American Society for Clinical Pathology, and Sigma Xi.
Selected Recent Publications:
Hill DA, Jarzembowski JA, Lennerz JK, Priest JR, Williams, G, Spence D, Schoettler P, Dehner LP. Type I pleuropulmonary blastoma (PPB): pathology and biology study of 51 cases. Am J Surg Pathol, manuscript in press.
Subramanian C, Jarzembowski JA, Opipari Jr AW, Castle VP, Kwok RPS. CREB-binding protein is a mediator of neuroblastoma cell death induced by the histone deacetylase inhibitor trichostatin A. Neoplasia 2007;9(6):495-503.
Jarzembowski JA, Lloyd RV, McKeever PA. Type IV collagen immunostaining is a simple, reliable diagnostic tool for distinguishing between adenomatous and normal pituitary glands. Arch Pathol Lab Med 2007;131:931-935.
Martin DT, Gendron RL, Jarzembowski JA, Perry A, Collins MH, Pushpanathan C, Miskiewicz E, Castle VP, Paradis H. Tubedown expression correlates with the differentiation status and aggressiveness of neuroblastic tumors. Clin Cancer Res 2007;13(5):1480-1487.
Akers AY, Jarzembowski JA, Johnson C, Lieberman RW, Dalton VK. Examining the relationship between positive mid-gestational fetal fibronectin assays and acute histologic placental inflammation at delivery. J Perinatal Med 2007:35;36-42.